{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05271604",
            "orgStudyIdInfo": {
                "id": "BA3021-002"
            },
            "organization": {
                "fullName": "BioAtla, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck",
            "officialTitle": "A Phase 2 Open-Label Study of Ozuriftamab Vedotin (BA3021) in PD-1/L1 Failure Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-phase-open-label-study-of-in-patients-with-recurrent-or-metastatic-squamous-cell-carcinoma-of-the-head-and-neck"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-09",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2022-12-13",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-02-28",
            "studyFirstSubmitQcDate": "2022-02-28",
            "studyFirstPostDateStruct": {
                "date": "2022-03-09",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-09-27",
            "lastUpdatePostDateStruct": {
                "date": "2023-09-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "BioAtla, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a multi-center, open-label Phase 2 study designed to evaluate the efficacy and safety of BA3021 in PD-1/L1 failure patients with ROR-2 expression in recurrent or metastatic squamous cell carcinoma of the head and neck."
        },
        "conditionsModule": {
            "conditions": [
                "Head and Neck Cancer",
                "Squamous Cell Carcinoma of Head and Neck",
                "Recurrent Squamous Cell Carcinoma of the Head and Neck",
                "Metastatic Cancer",
                "Metastatic Squamous Cell Carcinoma of the Head and Neck"
            ],
            "keywords": [
                "Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 80,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "BA3021 Q2W dosing",
                    "type": "EXPERIMENTAL",
                    "description": "BA3021 Q2W dosing regimen",
                    "interventionNames": [
                        "Biological: Ozuriftamab Vedotin",
                        "Biological: PD-1 inhibitor"
                    ]
                },
                {
                    "label": "BA3021 2Q3W dosing",
                    "type": "EXPERIMENTAL",
                    "description": "BA3021 2Q3W dosing regimen",
                    "interventionNames": [
                        "Biological: Ozuriftamab Vedotin",
                        "Biological: PD-1 inhibitor"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "Ozuriftamab Vedotin",
                    "description": "Conditionally active biologic anti-ROR2 antibody drug conjugate",
                    "armGroupLabels": [
                        "BA3021 2Q3W dosing",
                        "BA3021 Q2W dosing"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "PD-1 inhibitor",
                    "description": "PD-1 inhibitor",
                    "armGroupLabels": [
                        "BA3021 2Q3W dosing",
                        "BA3021 Q2W dosing"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Confirmed Objective Response Rate (ORR) per RECIST v1.1",
                    "description": "Proportion of patients who achieve a confirmed CR or PR according to RECIST v1.1",
                    "timeFrame": "Up to 24 months"
                },
                {
                    "measure": "Incidence of Adverse Events or Serious Adverse Events as assessed by CTCAE v5",
                    "description": "Measured by frequency and severity of adverse events as assessed by CTCAE v5",
                    "timeFrame": "Up to 24 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Duration of response (DOR)",
                    "description": "Time from the first documented OR until the first documented disease progression or death (due to any cause), whichever occurs first",
                    "timeFrame": "Up to 24 months"
                },
                {
                    "measure": "Progression-free survival (PFS)",
                    "description": "Time from the first dose of IP until the first documentation of disease progression or death due to any cause, whichever occurs first.",
                    "timeFrame": "Up to 24 months"
                },
                {
                    "measure": "Best overall response (OR)",
                    "description": "All post-baseline disease assessments that occur prior to the initiation of subsequent anticancer therapy",
                    "timeFrame": "Up to 24 months"
                },
                {
                    "measure": "Disease control rate (DCR)",
                    "description": "Proportion of patients with a best overall response of confirmed CR, confirmed PR, or stable disease (SD) \u2265 12 weeks.",
                    "timeFrame": "Up to 24 months"
                },
                {
                    "measure": "Time to response (TTR)",
                    "description": "Time from the first dose of investigational product until the first documentation of OR.",
                    "timeFrame": "Up to 24 months"
                },
                {
                    "measure": "Overall survival (OS)",
                    "description": "Time from the first dose of BA3021 treatment until death due to any cause.",
                    "timeFrame": "Up to 24 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically or cytologically confirmed recurrent or metastatic SCCHN Stage III/IV and not amenable to local therapy with curative intent (surgery or radiation therapy with or without chemotherapy). The eligible primary tumor locations are oropharynx, oral cavity, hypopharynx, and larynx. Patients may not have a primary tumor site of nasopharynx (any histology).\n* Documented treatment failure of no more than one approved PD-1/L1 inhibitor either administered alone or in combination.\n\nPatients must have measurable disease.\n\n* Age \u2265 18 years\n* Adequate renal function\n* Adequate liver function\n* Adequate hematological function\n* Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.\n\nExclusion Criteria:\n\n* Patients must not have a history of \u2265 Grade 3 allergic reactions to mAb therapy as well as known or suspected allergy or intolerance to any agent given during this study.\n* Patients must not have known human immunodeficiency virus (HIV) infection, active hepatitis B and/or hepatitis C.\n* Patients must not be women who are pregnant or breast feeding.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "BioAtla Medical Affairs",
                    "role": "CONTACT",
                    "phone": "858-558-0708",
                    "phoneExt": "3333",
                    "email": "medicalaffairs@bioatla.com"
                }
            ],
            "locations": [
                {
                    "facility": "USC Norris Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90033",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Azucena Vera",
                            "role": "CONTACT",
                            "email": "Azucena.Vera@med.usc.edu"
                        },
                        {
                            "name": "Jacob Thomas, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Christiana Care Helen Graham Cancer Center",
                    "status": "RECRUITING",
                    "city": "Newark",
                    "state": "Delaware",
                    "zip": "19713",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Denise DeMaio",
                            "role": "CONTACT",
                            "email": "Denise.a.demaio@christianacare.org"
                        },
                        {
                            "name": "Jamal Misleh, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.68372,
                        "lon": -75.74966
                    }
                },
                {
                    "facility": "Northwestern University",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Briana Porwisz",
                            "role": "CONTACT",
                            "email": "briana.porwisz@northwestern.edu"
                        },
                        {
                            "name": "Jochen Lorch, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Norton Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Louisville",
                    "state": "Kentucky",
                    "zip": "40202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Gracie Smith",
                            "role": "CONTACT",
                            "email": "gracie.smith@nortonhealthcare.org"
                        },
                        {
                            "name": "Jaspreet Grewal, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.25424,
                        "lon": -85.75941
                    }
                },
                {
                    "facility": "Washington University Medical Siteman Cancer Center",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Justin Alberti",
                            "role": "CONTACT",
                            "email": "jalberti@wustl.edu"
                        },
                        {
                            "name": "Douglas Adkins, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Memorial Sloan-Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Diana Frias",
                            "role": "CONTACT",
                            "email": "friasd1@mskcc.org"
                        },
                        {
                            "name": "Winston Wong, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Oregon Health & Science University",
                    "status": "RECRUITING",
                    "city": "Portland",
                    "state": "Oregon",
                    "zip": "97239",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "OHSU Knight Cancer Institute Clinical Trials",
                            "role": "CONTACT",
                            "email": "trials@ohsu.edu"
                        },
                        {
                            "name": "Jeremy Cetnar, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.52345,
                        "lon": -122.67621
                    }
                },
                {
                    "facility": "Huntsman Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Salt Lake City",
                    "state": "Utah",
                    "zip": "84112",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kaitlin Stephens",
                            "role": "CONTACT",
                            "email": "Kaitlin.stephens@hci.utah.edu"
                        },
                        {
                            "name": "Jeffrey Russell, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.76078,
                        "lon": -111.89105
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000002294",
                    "term": "Carcinoma, Squamous Cell"
                },
                {
                    "id": "D000077195",
                    "term": "Squamous Cell Carcinoma of Head and Neck"
                },
                {
                    "id": "D000012008",
                    "term": "Recurrence"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000018307",
                    "term": "Neoplasms, Squamous Cell"
                },
                {
                    "id": "D000006258",
                    "term": "Head and Neck Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "asFound": "Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1689",
                    "name": "Squamous Cell Carcinoma of Head and Neck",
                    "asFound": "Squamous Cell Carcinoma of the Head and Neck",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14850",
                    "name": "Recurrence",
                    "asFound": "Recurrent",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12307",
                    "name": "Neoplasm Metastasis",
                    "relevance": "LOW"
                },
                {
                    "id": "M5550",
                    "name": "Carcinoma, Squamous Cell",
                    "asFound": "Squamous Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9348",
                    "name": "Head and Neck Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M20451",
                    "name": "Neoplasms, Squamous Cell",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000082082",
                    "term": "Immune Checkpoint Inhibitors"
                }
            ],
            "ancestors": [
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "asFound": "PCA",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                }
            ]
        }
    },
    "hasResults": false
}